Nirmal Bang has maintained hold rating on Ajanta Pharma with a target price of Rs 318 in its July 4, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!